Literature DB >> 3777915

Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents.

T Lambert, F Mégraud, G Gerbaud, P Courvalin.   

Abstract

The susceptibility of 50 strains of Campylobacter pyloridis, isolated from human gastric biopsies, to 20 antimicrobial agents representing the different families of antibiotics was tested. The pattern of susceptibility was similar to that of the C. jejuni-C. coli group except for ampicillin, cephalothin, and rifampin. The relative resistance to cefsulodin was also noted.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3777915      PMCID： PMC180591          DOI： 10.1128/AAC.30.3.510

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Campylobacter enteritis: a "new" disease.

Authors:  M B Skirrow
Journal:  Br Med J       Date:  1977-07-02

2.  Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.

Authors:  C A McNulty; J Dent; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

3.  Spiral bacteria of the gastric antrum.

Authors:  C A McNulty; D M Watson
Journal:  Lancet       Date:  1984-05-12       Impact factor: 79.321

4.  Structural relationship between the genes encoding 3'-aminoglycoside phosphotransferases in Campylobacter and in gram-positive cocci.

Authors:  T Lambert; G Gerbaud; P Trieu-Cuot; P Courvalin
Journal:  Ann Inst Pasteur Microbiol (1985)       Date:  1985 Sep-Oct

5.  Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors.

Authors:  D E Taylor; L K Ng; H Lior
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

6.  Characterization of "Campylobacter pyloridis" by culture, enzymatic profile, and protein content.

Authors:  F Megraud; F Bonnet; M Garnier; H Lamouliatte
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

7.  Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa.

Authors:  C S Goodwin; E D Blincow; J R Warren; T E Waters; C R Sanderson; L Easton
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

8.  In vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agents.

Authors:  B M Flores; C L Fennell; K K Holmes; W E Stamm
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

9.  Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compounds.

Authors:  Z Elharrif; F Mégraud; A M Marchand
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

10.  Pyloric Campylobacter infection and gastroduodenal disease.

Authors:  B J Marshall; D B McGechie; P A Rogers; R J Glancy
Journal:  Med J Aust       Date:  1985-04-15       Impact factor: 7.738
View more
  31 in total

1.  Direct and indirect methods of measuring Helicobacter pylori drug susceptibility in vitro.

Authors:  A McLaren
Journal:  Mol Biotechnol       Date:  1999-12-15       Impact factor: 2.695

2.  Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.

Authors:  T Iwahi; H Satoh; M Nakao; T Iwasaki; T Yamazaki; K Kubo; T Tamura; A Imada
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

3.  In vitro selection of resistant Helicobacter pylori.

Authors:  C E Haas; D E Nix; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

4.  Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study.

Authors:  F Mégraud; N Lehn; T Lind; E Bayerdörffer; C O'Morain; R Spiller; P Unge; S V van Zanten; M Wrangstadh; C F Burman
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

5.  Assessment of metronidazole susceptibility in Helicobacter pylori: statistical validation and error rate analysis of breakpoints determined by the disk diffusion test.

Authors:  S Chaves; M Gadanho; R Tenreiro; J Cabrita
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 6.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

7.  Comparative sensitivities to antimicrobial agents of Campylobacter pylori and the gastric campylobacter like organism from the ferret.

Authors:  L Jeffries; D E Buckley; P R Blower; J N Plumb
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

8.  Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases.

Authors:  P E Coudron; C W Stratton
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

9.  Comparison of selective and nonselective media for recovery of Campylobacter pylori from antral biopsies.

Authors:  S Krajden; J Bohnen; J Anderson; J Kempston; M Fuksa; A Matlow; N Marcon; G Haber; P Kortan; M Karmali
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

10.  In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori).

Authors:  D L Van Caekenberghe; J Breyssens
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.